№ lp_1_2_41956
File format: docx
Character count: 14204
File size: 923 KB
Year:
2026
Region / City:
Scotland
Topic:
Paediatric Rheumatology, Iloprost Treatment
Document Type:
Medical Guideline
Author:
Scottish Paediatric & Adolescent Rheumatology Network
Target Audience:
Healthcare professionals involved in paediatric rheumatology
Period of Validity:
June 2026
Approval Date:
June 2026
Date of Changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
Not specified
Region / City:
Not specified
Topic:
Author disclosure, conflicts of interest
Document type:
Author disclosure form
Organization / Institution:
Rheumatology
Author:
Not specified
Target audience:
Authors of manuscripts submitted to Rheumatology
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Institution:
University of Colorado, Anschutz Medical Campus
Department:
Division of Rheumatology
Document Type:
Onboarding Letter
Authors:
Rachael Fuhrman, Jason R. Kolfenbach, M.D.
Target Audience:
Incoming Rheumatology Fellows
Associated Locations:
VA Medical Center, Denver Health, UCHealth
Due Dates:
Various (April 5th, April 12th, May 1st, June 11th, July 31st)
Related Systems:
OneDrive, Docusign, MedHub
Training Requirements:
VHA Mandatory Training, local policy acknowledgements, orientation handbooks
Context:
Official onboarding correspondence outlining required actions, deadlines, and document submissions for new rheumatology fellows at a university-affiliated medical program.
Year:
2023
Region / City:
Tallaght
Subject:
Rheumatology Patient Queries
Document Type:
Form
Organization / Institution:
Tallaght University Hospital
Author:
Tallaght University Hospital
Target Audience:
Patients of Tallaght University Hospital
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2025
Region / city:
UK
Topic:
Rheumatology, Axial Spondyloarthritis
Document type:
Guideline
Organization / institution:
British Society for Rheumatology
Author:
Sizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, Max Yates, Joe Eddison, Antoni Chan, Nick Clarke, Nadia Corp, Charlotte Davis, Lambert Felix, Kalveer Flora, William J Gregory, Gareth T Jones, Christopher A Lamb, Helena Marzo-Ortega, Daniel J Murphy, Harry Petrushkin, Virinderjit Sandhu, Raj Sengupta, Stefan Siebert, Danielle A Van Der Windt, Dale Webb, Zenas Z N Yiu, Karl Gaffney
Target audience:
Health professionals, rheumatologists
Period of validity:
Ongoing
Approval date:
2025
Date of changes:
Not specified
Context:
This is a clinical guideline for treating axial spondyloarthritis with biologic and targeted synthetic DMARDs.
Year:
2026
Region / City:
Worcestershire, UK
Topic:
Medical Referral Form
Document Type:
Referral Form
Institution:
Worcestershire Acute Hospitals NHS Trust
Author:
Not specified
Target Audience:
Healthcare professionals
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / city:
Liverpool
Topic:
Clinical psychology resources for children and young people with rheumatological conditions
Document type:
Leaflet
Organization:
Alder Hey Children’s NHS Foundation Trust
Author:
Sally Bell & Marilena Hadjittofi
Target audience:
Children, young people, and their families dealing with rheumatological conditions
Period of validity:
Until May 2026
Date of approval:
May 2026
Date of revisions:
None stated
Note:
Year
Region / City:
Northland
Theme:
Rheumatology, Clinical Trials
Document Type:
Clinical Trial Protocols
Institution:
KCPP
Author:
Micah Judd, Naishi Kachadiya
Target Audience:
Healthcare Providers, Researchers, Clinical Trial Coordinators
Period of Validity:
Ongoing
Study Type:
Randomized, Double-blind, Placebo-controlled
Interventions:
Rinvoq, Taltz, Zepbound, Dazodalibep, Guselkumab
Study Purpose:
Evaluation of treatments for rheumatoid arthritis, psoriatic arthritis, lupus, Sjogren’s syndrome
Study Design:
Parallel-arm, Open Label, Biospecimen Collection, Registry Trial
Year:
Not specified
Region / City:
Not specified
Subject:
Paediatric fracture management
Document type:
Clinical guidelines
Author:
Not specified
Target audience:
Healthcare professionals, specifically in paediatric fracture care
Approval date:
Not specified
Modification date:
Not specified
Year:
2026
Region / City:
United Kingdom
Topic:
Paediatric fatigue assessment and referral
Document Type:
Referral Form
Organization / Institution:
NHS
Author:
Not specified
Target Audience:
Healthcare professionals
Period of Validity:
Indefinite
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2022
Region / city:
Birmingham
Subject:
Paediatric Oncology and Haematology
Document type:
Capability Framework
Organization / institution:
Royal College of Nursing, Children’s Cancer and Leukaemia Group (CCLG)
Author:
Sally Spencer, Helen Woodman
Target audience:
Advanced Clinical Practitioners, Clinical Supervisors
Period of validity:
Until March 2023
Date of approval:
March 2022
Date of revisions:
Annually for first three years, then every three years
Year:
2023
Region / City:
Canberra
Theme:
Sepsis management
Document Type:
Guideline
Institution:
Canberra Health Services
Author:
Canberra Health Services Team
Target Audience:
Medical Team members, Registered Nurses and Midwives, Enrolled Nurses, Pharmacists, Allied Health professionals
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2022
Region / City:
ACT and surrounding NSW
Topic:
Paediatric Diabetes Care, Insulin Pump Therapy
Document Type:
Clinical Guideline
Organization:
Canberra Health Services (CHS)
Author:
Canberra Health Services, Paediatric Endocrinology and Diabetes Service
Target Audience:
Paediatric Diabetes Healthcare Providers
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Revision:
N/A
Year:
2023
Region / City:
Canberra
Topic:
Paediatric Parenteral Nutrition
Document Type:
Guideline
Organization / Institution:
Canberra Health Services
Author:
SCHN Multidisciplinary Team
Target Audience:
Clinicians, Parents/Carers
Effective Period:
Not specified
Approval Date:
13/06/2023
Amendment Date:
13/06/2023
Note:
Year
Region / City:
Canberra
Topic:
Paediatric Care, Health Services
Document Type:
Guideline
Institution:
Canberra Health Services
Target Audience:
Medical, nursing, and allied health staff
Year:
2023
Region / City:
Australia
Topic:
Communicable diseases, paediatric surveillance
Document Type:
Annual report
Organisation / Institution:
Australian Paediatric Surveillance Unit (APSU)
Author:
Suzy M Teutsch, Carlos A Nunez, Anne Morris, Guy D Eslick, Elizabeth J Elliott
Target Audience:
Healthcare professionals, public health authorities
Period of Validity:
2022
Approval Date:
24/8/2023
Date of Last Update:
N/A
Year:
2026
Region / City:
Liverpool
Topic:
Paediatric Health, Medical Conditions
Document Type:
Information Leaflet
Author:
Unknown
Target Audience:
Parents and carers of children diagnosed with ITP
Period of Validity:
Until February 2028
Approval Date:
Unknown
Review Date:
February 2028
Year:
2024
Region / City:
Wales
Topic:
Inflammatory Bowel Disease, Faecal Calprotectin Testing
Document Type:
Policy
Organization / Institution:
NHS Wales
Author:
Dr Clare Tibbatts, Dr Amar Wahid, Dr Claire Thomas
Target Audience:
Healthcare professionals in primary and secondary care in Wales
Period of Validity:
Indefinite
Approval Date:
November 2024
Modification Date:
N/A
Year:
2023
Region / City:
Australia
Theme:
Paediatric Oncology, Pharmacology
Document Type:
Medical Submission
Organization / Institution:
Novartis Pharmaceuticals Australia Pty Limited
Author:
Novartis Pharmaceuticals Australia Pty Limited
Target Audience:
Medical practitioners, oncologists, pharmacists, healthcare providers
Period of Validity:
Not specified
Approval Date:
6 December 2023
Date of Amendments:
Not specified
Year:
2018
Region / City:
Southampton, UK; Chapel Hill, North Carolina, USA; Toronto, Ontario, Canada; Miami, Florida, USA; London, UK
Topic:
Paediatric health-related quality of life instruments, Primary ciliary dyskinesia
Document Type:
Research article
Author:
Laura Behan, Margaret W Leigh, Sharon D Dell, Alexandra L Quittner, Claire Hogg, Jane S Lucas
Target Audience:
Researchers, clinicians, healthcare professionals, and institutions involved in rare diseases and respiratory medicine
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A